| Code | 43039 | ||||||||||
| MA number | 59/0073/05-S | ||||||||||
| Product Form: | tbl ent 20x180 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PA/Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 31.03.2005 |
| Pediatric warnings: | Yes |
| Dokument: |
DHPC mykofenolat 3 12 2015.pdf
|
| SPC: |
SPC_Myfortic 180 mg_02.2023.pdf
|
| PIL: |
PIL_Myfortic 180 mg_01.2024.pdf
|
| Safety feature | Yes |
| Data update: | 20.10.2022 |
